Human Milk Oligosaccharides (HMO) such as 2’-fucosyllactose (2’-FL), and galactooligosaccharides (GOS) that are added to infant formula may offer protection against bacterium known to cause tooth decay.
Regulators from China and importing countries should cooperate to arrest the problem of milk formula not intended for infant consumption being marketed as such in the China market, said an industry observer.
Danone's production facility in Ireland is the first baby formula production site in the world to be certified carbon neutral by the Carbon Trust, an independent global climate change and sustainability consultancy.
There is currently only low-certainty evidence to show that consuming galactagogues can increase breast milk production in nursing mothers, with a group of Malaysian researchers who conducted a recent Cochrane systematic review recommending further studies...
Countries are failing to protect parents from the ‘harmful’ promotion of breast-milk substitutes, despite efforts by The World Health Organization (WHO), UNICEF, and the International Baby Food Action Network (IBFAN).
Research involving Jennewein Biotechnologie suggests breast-fed infants are less likely than bottle-fed infants to contract norovirus infections, adding weight to the protective effects of Human Milk Oligosaccharides (HMOs).
Health and nutrition claims used in the marketing of infant and follow-on formula should be prohibited, paediatric experts think as they argue the claims may undermine efforts to support breastfeeding.